|

Aspirin + Clopidogrel Clinical Trials

2 actively recruiting trials

Also known as: Dual Antiplatelet Therapy

Pipeline

Phase 4: 1

Top Sponsors

  • Xijing Hospital1
  • China National Center for Cardiovascular Diseases1

Indications

  • Percutaneous Coronary Intervention2
  • Heart Disease2
  • Acute Coronary Syndrome1
  • Atrial Fibrillation1
  • Coronary Artery Disease1

Other2 trials

LAAO Versus NOAC in Patients with AF and PCI
N/A
NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.